Clyto Online Publishing | Conference | Global Bioanalysis Summit

Welcome to Global Bioanalysis Summit

Global Bioanalysis Summit 2017 will be held in the USA on 18-20 September 2017 with the theme “Discussing current trends and future scope in bioanalysis”. The conference aims to bring together outstanding academic scientists, researchers and research scholars to exchange and contribute their experiences and research results on all facets of Bioanalysis. You will meet with the experts from all over the world who are working on Bioanalysis of biological samples, drugs and other metabolites of great interest. The summit is committed to providing a challenging and thought-provoking experience through engaging you in the professional theme.

Global Bioanalysis Summit 2017 is providing a platform for professionals like Research scientists, Application specialists, Chemists, Investigator, Professors, Bioanalysts and fellows in Bioanalytical and Chemical sciences and all faculty/students from university/institutes.
Global Bioanalysis Summit 2017 is enabling all professionals:
• to discuss various bioanalytical techniques such as hyphenated techniques, chromatographic techniques, and ligand binding assays, Metabolomics Analysis, chemiluminescence sensor for the detection of cholesterol, photoelectrochemical biosensor, Liquid extraction surface analysis mass spectrometry imaging.
• to discuss the modern challenges of Bioanalysts
• to discuss the role of bioanalysis on Novel drug delivery system.
 

Bioanalysis has significantly developed from early studies in drug metabolism to the sophisticated advanced techniques. Today bioanalysis is the most challenging area and bioanalysts are now involved with the discovery, measurement and qualification of pharmacogenomic profiles and biomarkers. Eventually, the development of diagnostic kits to individualized patient characterization and better treatments.

MARKET ANALYSIS

The biologics market is estimated to be approximately $190-200 billion by 2015 with a growth rate of 9.9% from 2010. Increased share of large molecule in Pharma R&D pipeline have increased the demand for more Bioanalytical testing. In this scenario, Pharma companies are increasingly adopting outsourcing (from 26% of Bioanalytical spending in 2011-2012 to 36% in 2012-2013) as a strategy to contain cost, reduce time and access expertise. The growth in small molecule NCEs (New Chemical Entity) has been less than 1% per annum in contrast to that of large molecule NBE (New Biological Entity) which is about 25% from 2000 to 2010. Furthermore the sale of the small molecules is growing at a CAGR of 3.9% and that of large molecules at a CAGR of 10.1% from 2009 to 2015. The global advanced drug delivery market should grow from roughly $178.8 billion in 2015 to nearly $227.3 billion by 2020, with a compound annual growth rate (CAGR) of 4.9%. The global pharmaceutical market is expected to surpass US$400 bn by 2018. The development of biopharmaceuticals represents a milestone for the industry and personalized therapies carry immense promise in the near future.

CONFERENCE HIGHLIGHTS

The open panel discussion intend to have solemn discussion involving current challenges in the area of bioanalysis in which all attendees can interact with the panel followed by a Q/A session.
The attendees can interact with each other and exchange ideas that can be of great help to someone conducting analogous research.
Keynote speakers and speakers would share their expertise and their current research work. The students (Ph.D. and Post Doc. Fellows) can present their posters.
Keynote speakers and speakers would share their expertise and their current research work. The students (Ph.D. and Post Doc. Fellows) can present their posters.

SESSIONS

Bioanalysis is a progressive discipline for which the future holds many exciting opportunities to further reduce sample volumes, analysis cost and environmental impact, as well as to improve sensitivity, specificity, accuracy, efficiency, assay throughput, data quality, data handling and processing. 

Track 1-1: Small molecule bioanalysis

Track 1-2: Large molecule bioanalysis

Track 1-3: Elemental analysis

Track 1-4: Environmental analysis

Track 1-5: Quantitative bioanalysis

Track 1-6: Qualitative bioanalysis

Track 1-7: Food quality analysis

Track 1-8: Forensic Bioanalysis

The purpose of including bioassay in bioanalytical techniques is to compare the test substance with the International Standard preparation of the same and to find out how much test substance is required to produce the same biological effect, as produced by the standard.

Track 2-1: Biomarker assays

Track 2-2: Diagnostic assays & Test kits

Track 2-3: Drug and metabolite assays

Track 2-4: Ligand binding assays

Track 2-5: Pharmacogenomics assays

Track 2-6: Cell-based bioassays

Track 2-7: Bioassays – methods in use

Track 2-8: Radioimmunoassays

Bioanalytical techniques and methods are being used for the detection or quantitative study of human or animal biological samples. Bioanalysis  encourages the submission of articles describing forward-looking applications, including biosensors, microfluidics, miniaturized analytical devices, and new hyphenated and multi-dimensional techniques.

Track 3-1: Innovative bioanalytical methods

Track 3-2: Mass spectrometry

Track 3-3: Electrophoresis

Track 3-4: HPLC-MS/MS

Track 3-5: MS-NMR

Track 3-6: Pharmaceutical analytical techniques

Track 3-7: Chromatography and separation science

Track 3-8: Hyphenated techniques

Before a bioanalytical method can be implemented for routine use, it is widely agreed that it must first be validated to demonstrate that it is suitable for its intended purpose.

Track 4-1: Validation parameters and limitations

Track 4-2: Reference standards

Track 4-3: Analyte stability validation

Track 4-4: Regulatory and compliance issues

Track 4-5: Detector

Drug discovery and development is the process of generating compounds and evaluating all their properties to determine the feasibility of selecting one novel chemical entity (NCE) to become a safe and efficacious drug. It is widely accepted that bioanalysis is an integral part of the pharmacokinetic/pharmacodynamic characterization of an NCE.

Track 5-1: Metabolite profiling

Track 5-2: Drug design

Track 5-3: HPLC-Q-TOF

Track 5-4: QqQ- MS

Track 5-5: ESI

Track 5-6: Drug developmental stages

Track 5-7: Drug Metabolism

Sometimes food items contain residues of pesticides, veterinary and human drugs, microbial toxins, preservatives, contaminants from food processing and packaging, and other residues. Novel bioanalytical methods are required for analysis of these food contaminants.

Track 6-1: Methods for pesticides determination

Track 6-2: Rapid analysis methods

Track 6-3: Food quality analysis

Track 6-4: Microbial contamination analysis

Track 6-5: Meat and pesticides testing

Track 6-6: Biosensors for food safety

Track 6-7: Analysis for Food Preservation

Automation and robotics have been effectively integrated into bioanalytical methodologies and processes to maximize sample processing throughput and the quality of data.

Track 7-1: Laboratory automation and efficiency

Track 7-2: Automated sample preparation

Track 7-3: Online and automated extraction

Track 7-4: Dried blood spot analysis

Track 7-5: Standardized kits for automated sample analysis

The general trend in bioanalytical instrumentation is the improvement of functionalities and the simultaneous shrinking in the physical size of the lab. The modern advancements aim at the bioanalytical laboratory in a box.

Track 8-1: ECL biosensor measurement

Track 8-2: Fully automated sample preparation

Track 8-3: Liquid handling robots

Track 8-4: Laboratory automation

Track 9-1: Mass spectrometer

Track 9-2: Infra-red spectra

Track 9-3: Nuclear magnetic resonance (NMR)

Track 9-4: UV-visible absorption spectra

Track 9-5: Capillary Electrophoresis

Track 9-6: Cyclic Voltammetry

Track 9-7: Microscopy

Track 9-8: Lasers

Track 9-9: Diffraction

Track 9-10: Photospectrometry

Track 9-11: Raman Spectroscopy

Track 9-12: Bioreactors

Track10-1 Parameters in environmental Analysis

Track10-2 Environmental Monitoring conditions

Track10-3 Chemical Oxygen Cycle

Track10-4 Biological Cycle

Track10-5 Volatile Organic Compounds Analysis

Track10-6 Air Quality Analysis

Track10-7 Soil Testing

Track10-8 Water Quality Testing

Track10-9 Waste Management Analysis

Track10-10 Pollution Control

Track11-1:Ion and Non-ion Elements

Track11-2: Trace Elements

Track11-3:System Suitability

Track11-4:Biological Materials „

Track11-5:Environmental Materials „

Track11-6:Geological Materials

Track11-7:Major Elements & Minor Elements

Track 12-1:Filtration

Track 12-2:Liquid-Liquid Extraction

Track 12-3:Solid supported liquid extraction (SLE)

Track 12-4:Solid phase extraction (SPE)

Track 12-5:Liquid/liquid extraction (LLE, SLE)

Organizing Committee

Our Speakers

Programs Programs Detail Time
1

SPOT REGISTRATIONS

08:00 AM
2

INAUGURATION OF GLOBAL BIOANALYSIS SUMMIT 2017

09:00 AM
3

KEYNOTE SESSIONS #1

09:30 AM
4

REFRESHMENTS BREAK

10:30 AM
5

KEYNOTE SESSIONS #2

11:00 AM
6

REFRESHMENTS - LUNCH BREAK

12:30 PM
7

SCIENTIFIC SESSIONS - SPEECH OPPORTUNITY AVAILABLE

01:30 PM
8

SCIENTIFIC SESSIONS - SPEECH OPPORTUNITY AVAILABLE

03:30 PM
9

DAY #1 - CLOSURE

06:00 PM

venue

TBD

address

TBD


Reach Us at


Clyto Access (USA)
  • 600 West Broadway Suite 700
  • San Diego CA 92101 | USA
  • Phone: 1-619-471-1648

Clyto Access (India)
  • Novel Business Center
  • 10 BTM Layout 1 | Bengaluru,
  • Karnataka 560068 | India
  • Phone: 91-080-41474547

www.clytoaccess.com
contact@clytoaccess.com
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright © Clytoaccess 2017